A parallel randomised controlled trial of the Hypoglycaemia Awareness Restoration Programme for adults with type 1 diabetes and problematic hypoglycaemia despite optimised self-care (HARPdoc)
Psychoeducation
Depression
DOI:
10.1038/s41467-022-29488-x
Publication Date:
2022-04-28T10:04:48Z
AUTHORS (17)
ABSTRACT
Abstract Impaired awareness of hypoglycaemia (IAH) is a major risk for severe in insulin treatment type 1 diabetes (T1D). To explore the hypothesis that unhelpful health beliefs create barriers to regaining awareness, we conducted multi-centre, randomised, parallel, two-arm trial (ClinicalTrials.gov NCT02940873) adults with T1D and treatment-resistant IAH hypoglycaemia, blinded analysis 12-month recall at 12 and/or 24 months primary outcome. Secondary outcomes included cognitive emotional measures. Adults T1D, despite structured education adjustment, +/− technologies, were randomised “Hypoglycaemia Awareness Restoration Programme optimised self-care” (HARPdoc, n = 49), psychoeducation programme uniquely focussing on changing avoiding or evidence-based “Blood Glucose Training” (BGAT, 50), both delivered over six weeks. Median [IQR] baseline was 5[2–12] per patient/year, 1[0–5] 0[0–2] months, no superiority HARPdoc (HARPdoc vs BGAT incident rate ratios [95% CI] 1.25[0.51, 3.09], p 0.62 1.26[0.48, 3.35], 0.64 respectively), nor changes scores fear. Compared BGAT, significantly reduced endorsement cognitions (Estimated Mean Difference Attitudes −2.07 [−3.37,−0.560], 0.01) distress (−6.70[−12.50,−0.89], 0.02); depression (−1.86[−3.30, −0.43], anxiety (−1.89[−3.32, −0.47], 0.01). Despite positive impact around avoidance diabetes-related general scores, not more effective than reducing hypoglycaemia.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (52)
CITATIONS (44)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....